To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact of the covid-19 outbreak on funding for brain tumour research.
24 June 2021
During the COVID-19 pandemic, many National Institute for Health Research (NIHR) programmes, studies and trials were paused. However, the NIHR’s funding competitions remained open throughout, including for brain tumour research. Funding continues to be invested through the NIHR to support a wide range of research from early translation or experimental medicine, through clinical, and applied health and care research.